Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin
Clinical Surgical Oncology · 2022
DOI: 10.1016/j.cson.2022.100005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Surgical Oncology, 2022. Verfasst von Kenji Tomizawa und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tomizawa, K., Soh, J., Oiki, H., Fukuda, S., Nishino, M., Sato, K., & Mitsudomi, T. (2022). Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin. Clinical Surgical Oncology. https://doi.org/10.1016/j.cson.2022.100005
Vancouver
Tomizawa K, Soh J, Oiki H, Fukuda S, Nishino M, Sato K, et al. Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin. Clinical Surgical Oncology. 2022. doi:10.1016/j.cson.2022.100005
BibTeX
@article{Tomizawa2022,
author = {Tomizawa, Kenji and Soh, Junichi and Oiki, Hana and Fukuda, Shota and Nishino, Masaya and Sato, Katsuaki and Mitsudomi, Tetsuya},
title = {Propensity score analysis for the efficacy of preoperative antibiotics in patients with resected primary lung cancer: Levofloxacin versus cefazolin},
journal = {Clinical Surgical Oncology},
year = {2022},
doi = {10.1016/j.cson.2022.100005}
}
EUVIMED